HCW Biologics annual gross margin
2022
2023
2024
2025
HCW Biologics's gross margin was 20.00% for fiscal 2025.
View full HCW Biologics company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 20.00% | −17.38 pp |
| 2024 | 2024-12-31 | 37.38% | +17.66 pp |
| 2023 | 2023-12-31 | 19.72% | −18.76 pp |
| 2022 | 2022-12-31 | 38.48% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −77.13% | −97.13 pp |
| Q1 2026 | 2026-03-31 | 100.49% | +80.49 pp |
| Q4 2025 | 2025-12-31 | 20.00% | −0.00 pp |
| Q3 2025 | 2025-09-30 | 20.00% | −0.00 pp |
| Q2 2025 | 2025-06-30 | 20.00% | −9.15 pp |
| Q1 2025 | 2025-03-31 | 20.00% | −34.56 pp |
| Q4 2024 | 2024-12-31 | 20.00% | +0.92 pp |
| Q3 2024 | 2024-09-30 | 20.00% | −0.49 pp |
| Q2 2024 | 2024-06-30 | 29.15% | +9.82 pp |
| Q1 2024 | 2024-03-31 | 54.56% | +24.64 pp |
| Q4 2023 | 2023-12-31 | 19.08% | −0.92 pp |
| Q3 2023 | 2023-09-30 | 20.49% | +0.49 pp |
| Q2 2023 | 2023-06-30 | 19.33% | −17.41 pp |
| Q1 2023 | 2023-03-31 | 29.92% | −27.48 pp |
| Q4 2022 | 2022-12-31 | 20.00% | — |
| Q3 2022 | 2022-09-30 | 20.00% | — |
| Q2 2022 | 2022-06-30 | 36.74% | — |
| Q1 2022 | 2022-03-31 | 57.40% | — |
Across the available reported history, HCW Biologics's gross margin decreased from 37.38% to 20.00%, a change of −17.38 percentage points. The latest reported quarter, Q2 2026, shows −77.13%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCW Biologics filings at SEC.gov ↗